Nicotine may affect bodily processes – as well as perhaps the actions of other generally used drugs – more broadly than was previously thought. This advance may lead to the development of new remedies to fight smoking addiction. Simultaneously, the finding could also have potential implications for diseases such as schizophrenia, Hawrot said. Recent genetic studies have suggested that some instances of schizophrenia are connected with deletions where a block of genes, including the gene for the alpha-7 receptor, is lacking.Patients took the assigned study drug for a mean of 424 times in the anacetrapib group and a mean of 483 times in the placebo group. As of October 26, 2010, follow-up assessments, with ascertainment of clinical basic safety end points, were comprehensive in 99.1 percent and 99.4 percent of the sufferers in the anacetrapib and placebo groups, respectively. The baseline features of the sufferers who were enrolled in the analysis are shown in Table 1Table 1Baseline Features of the analysis Patients.